News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
758,968 Results
Type
Article (66627)
Company Profile (644)
Press Release (691697)
Multimedia
Podcasts (107)
Webinars (12)
Section
Business (214888)
Career Advice (2589)
Deals (37952)
Drug Delivery (120)
Drug Development (86107)
Employer Resources (176)
FDA (16969)
Job Trends (16220)
News (364965)
Policy (33635)
Tag
Academia (2846)
Academic (1)
Accelerated approval (5)
Adcomms (24)
Allergies (92)
Alliances (53349)
ALS (99)
Alzheimer's disease (1486)
Antibody-drug conjugate (ADC) (155)
Approvals (16939)
Artificial intelligence (292)
Autoimmune disease (29)
Automation (16)
Bankruptcy (389)
Best Places to Work (12037)
BIOSECURE Act (22)
Biosimilars (117)
Biotechnology (439)
Bladder cancer (83)
Brain cancer (30)
Breast cancer (297)
Cancer (2427)
Cardiovascular disease (199)
Career advice (2161)
Career pathing (34)
CAR-T (171)
Cell therapy (479)
Cervical cancer (20)
Clinical research (69556)
Collaboration (917)
Company closure (1)
Compensation (556)
Complete response letters (30)
COVID-19 (2747)
CRISPR (48)
C-suite (269)
Cystic fibrosis (108)
Data (2282)
Decentralized trials (2)
Denatured (30)
Depression (56)
Diabetes (296)
Diagnostics (6753)
Digital health (20)
Diversity (7)
Diversity, equity & inclusion (41)
Drug discovery (130)
Drug pricing (122)
Drug shortages (30)
Duchenne muscular dystrophy (101)
Earnings (87297)
Editorial (44)
Employer branding (24)
Employer resources (152)
Events (120436)
Executive appointments (776)
FDA (18290)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (813)
Gene editing (120)
Generative AI (29)
Gene therapy (354)
GLP-1 (835)
Government (4064)
Grass and pollen (6)
Guidances (79)
Healthcare (19560)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (147)
Indications (30)
Infectious disease (2905)
Inflammatory bowel disease (153)
Inflation Reduction Act (9)
Influenza (55)
Intellectual property (100)
Interviews (494)
IPO (17485)
IRA (48)
Job creations (4668)
Job search strategy (1817)
Kidney cancer (11)
Labor market (37)
Layoffs (550)
Leadership (24)
Legal (8364)
Liver cancer (82)
Lung cancer (345)
Lymphoma (159)
Machine learning (7)
Management (61)
Manufacturing (344)
MASH (75)
Medical device (14194)
Medtech (14199)
Mergers & acquisitions (21028)
Metabolic disorders (779)
Multiple sclerosis (86)
NASH (22)
Neurodegenerative disease (113)
Neuropsychiatric disorders (34)
Neuroscience (2086)
NextGen: Class of 2025 (7012)
Non-profit (4478)
Now hiring (40)
Obesity (418)
Opinion (270)
Ovarian cancer (78)
Pain (102)
Pancreatic cancer (89)
Parkinson's disease (160)
Partnered (23)
Patents (252)
Patient recruitment (115)
Peanut (51)
People (61932)
Pharmaceutical (136)
Pharmacy benefit managers (21)
Phase I (21697)
Phase II (30541)
Phase III (22875)
Pipeline (1275)
Policy (164)
Postmarket research (2806)
Preclinical (9606)
Press Release (71)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (268)
Rare diseases (426)
Real estate (6749)
Recruiting (70)
Regulatory (23440)
Reports (35)
Research institute (2632)
Resumes & cover letters (391)
Rett syndrome (5)
RNA editing (5)
RSV (49)
Schizophrenia (79)
Series A (142)
Series B (93)
Service/supplier (27)
Sickle cell disease (58)
Special edition (17)
Spinal muscular atrophy (161)
Sponsored (31)
Startups (4047)
State (2)
Stomach cancer (15)
Supply chain (76)
Tariffs (49)
The Weekly (75)
Vaccines (776)
Venture capitalists (44)
Weight loss (297)
Women's health (35)
Worklife (20)
Date
Today (141)
Last 7 days (849)
Last 30 days (2864)
Last 365 days (34866)
2025 (11673)
2024 (37542)
2023 (42182)
2022 (53510)
2021 (57891)
2020 (56109)
2019 (48521)
2018 (36741)
2017 (35457)
2016 (35599)
2015 (41802)
2014 (35385)
2013 (31143)
2012 (32090)
2011 (32319)
2010 (30471)
Location
Africa (926)
Alabama (60)
Alaska (7)
Arizona (209)
Arkansas (13)
Asia (46921)
Australia (7966)
California (6456)
Canada (2071)
China (563)
Colorado (279)
Connecticut (295)
Delaware (158)
Europe (102489)
Florida (941)
Georgia (216)
Hawaii (1)
Idaho (63)
Illinois (577)
India (30)
Indiana (335)
Iowa (12)
Japan (172)
Kansas (107)
Kentucky (28)
Louisiana (13)
Maine (70)
Maryland (930)
Massachusetts (4965)
Michigan (239)
Minnesota (416)
Mississippi (2)
Missouri (90)
Montana (31)
Nebraska (26)
Nevada (64)
New Hampshire (67)
New Jersey (1826)
New Mexico (30)
New York (1836)
North Carolina (1112)
North Dakota (9)
Northern California (2768)
Ohio (217)
Oklahoma (13)
Oregon (45)
Pennsylvania (1422)
Puerto Rico (13)
Rhode Island (36)
South America (1328)
South Carolina (23)
South Dakota (1)
Southern California (2390)
Tennessee (103)
Texas (961)
United States (24586)
Utah (187)
Virginia (169)
Washington D.C. (71)
Washington State (601)
West Virginia (3)
Wisconsin (68)
758,968 Results for "sun pharma advanced research company ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sun Pharma to Acquire Checkpoint Therapeutics
March 10, 2025
·
24 min read
Press Releases
Sun Pharma and Moebius Medical Announce Dual Publications on MM-II’s Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage
April 24, 2025
·
5 min read
Deals
Taro Shareholders Approve Merger with Sun Pharma
Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. announced that the merger agreement between Taro and Sun Pharma was approved by the affirmative vote of Taro shareholders at an Extraordinary General Meeting and an Ordinary Class Meeting on May 22, 2024.
May 23, 2024
·
4 min read
Deals
Sun Pharma Completes Taro Merger
Sun Pharmaceutical Industries Limited today announced the successful completion of the merger of Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) with its subsidiary.
June 24, 2024
·
1 min read
Press Releases
Kairos Pharma Ltd. Provides Letter to Stockholders
April 24, 2025
·
5 min read
Press Releases
Sumitomo Pharma America enters into a Cooperative Research and Development Agreement with the National Cancer Institute to Advance Clinical Understanding of Enzomenib
April 14, 2025
·
5 min read
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
Press Releases
Mitsubishi Tanabe Pharma America to Highlight Latest Advances in Neurodegenerative Research at the American Academy of Neurology 2025 Annual Meeting
April 3, 2025
·
10 min read
Deals
Taro Announces Merger Agreement with Sun Pharma
Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. announced that they have entered into a definitive merger agreement in which Sun Pharma, Taro’s controlling shareholder, has agreed to acquire all of the outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliates for US$43.00 per share in cash without interest.
January 17, 2024
·
8 min read
Press Releases
Kairos Pharma, Ltd. Announces Data to be Presented at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
April 28, 2025
·
3 min read
1 of 75,897
Next
